T-cell therapy at the threshold
June, Carl, Rosenberg, Steven A, Sadelain, Michel, Weber, Jeffrey S
Published in Nature biotechnology (01.07.2012)
Published in Nature biotechnology (01.07.2012)
Get full text
Journal Article
Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor
Johnson, Douglas B, Flaherty, Keith T, Weber, Jeffrey S, Infante, Jeffrey R, Kim, Kevin B, Kefford, Richard F, Hamid, Omid, Schuchter, Lynn, Cebon, Jonathan, Sharfman, William H, McWilliams, Robert R, Sznol, Mario, Lawrence, Donald P, Gibney, Geoffrey T, Burris, 3rd, Howard A, Falchook, Gerald S, Algazi, Alain, Lewis, Karl, Long, Georgina V, Patel, Kiran, Ibrahim, Nageatte, Sun, Peng, Little, Shonda, Cunningham, Elizabeth, Sosman, Jeffrey A, Daud, Adil, Gonzalez, Rene
Published in Journal of clinical oncology (20.11.2014)
Published in Journal of clinical oncology (20.11.2014)
Get full text
Journal Article
Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies
Sloot, Sarah, Chen, Yian A., Zhao, Xiuhua, Weber, Jamie L., Benedict, Jacob J., Mulé, James J., Smalley, Keiran S., Weber, Jeffrey S., Zager, Jonathan S., Forsyth, Peter A., Sondak, Vernon K., Gibney, Geoffrey T.
Published in Cancer (15.01.2018)
Published in Cancer (15.01.2018)
Get full text
Journal Article
Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma
Campbell, Katie M., Amouzgar, Meelad, Pfeiffer, Shannon M., Howes, Timothy R., Medina, Egmidio, Travers, Michael, Steiner, Gabriela, Weber, Jeffrey S., Wolchok, Jedd D., Larkin, James, Hodi, F. Stephen, Boffo, Silvia, Salvador, Lisa, Tenney, Daniel, Tang, Tracy, Thompson, Marshall A., Spencer, Christine N., Wells, Daniel K., Ribas, Antoni
Published in Cancer cell (10.04.2023)
Published in Cancer cell (10.04.2023)
Get full text
Journal Article
Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy-Induced Immune-Related Adverse Events in Melanoma
Monson, Kelsey R, Ferguson, Robert, Handzlik, Joanna E, Xiong, Jiahan, Dagayev, Sasha, Morales, Leah, Chat, Vylyny, Bunis, Anabelle, Sreenivasaiah, Chaitra, Dolfi, Sonia, Tenney, Daniel J, Shao, Yongzhao, Osman, Iman, Weber, Jeffrey S, Kirchhoff, Tomas
Published in Clinical cancer research (01.10.2024)
Published in Clinical cancer research (01.10.2024)
Get full text
Journal Article
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGY (AACE) DISEASE STATE CLINICAL REVIEW EVALUATION AND MANAGEMENT OF IMMUNE CHECKPOINT INHIBITOR-MEDIATED ENDOCRINOPATHIES: A PRACTICAL CASE-BASED CLINICAL APPROACH
Yuen, Kevin C J, Samson, Susan L, Bancos, Irina, Gosmanov, Aidar R, Jasim, Sina, Fecher, Leslie A, Weber, Jeffrey S
Published in Endocrine practice (01.07.2022)
Published in Endocrine practice (01.07.2022)
Get more information
Journal Article
Classification of current anticancer immunotherapies
Galluzzi, Lorenzo, Vacchelli, Erika, Bravo-San Pedro, José-Manuel, Buqué, Aitziber, Senovilla, Laura, Baracco, Elisa Elena, Bloy, Norma, Castoldi, Francesca, Abastado, Jean-Pierre, Agostinis, Patrizia, Apte, Ron N., Aranda, Fernando, Ayyoub, Maha, Beckhove, Philipp, Blay, Jean-Yves, Bracci, Laura, Caignard, Anne, Castelli, Chiara, Cavallo, Federica, Celis, Estaban, Cerundolo, Vincenzo, Clayton, Aled, Colombo, Mario P., Coussens, Lisa, Dhodapkar, Madhav V., Eggermont, Alexander M., Fearon, Douglas T., Fridman, Wolf H., Fučíková, Jitka, Gabrilovich, Dmitry I., Galon, Jérôme, Garg, Abhishek, Ghiringhelli, François, Giaccone, Giuseppe, Gilboa, Eli, Gnjatic, Sacha, Hoos, Axel, Hosmalin, Anne, Jäger, Dirk, Kalinski, Pawel, Kärre, Klas, Kepp, Oliver, Kiessling, Rolf, Kirkwood, John M., Klein, Eva, Knuth, Alexander, Lewis, Claire E., Liblau, Roland, Lotze, Michael T., Lugli, Enrico, Mach, Jean-Pierre, Mattei, Fabrizio, Mavilio, Domenico, Melero, Ignacio, Melief, Cornelis J., Mittendorf, Elizabeth A., Moretta, Lorenzo, Odunsi, Adekunke, Okada, Hideho, Palucka, Anna Karolina, Peter, Marcus E., Pienta, Kenneth J., Porgador, Angel, Prendergast, George C., Rabinovich, Gabriel A., Restifo, Nicholas P., Rizvi, Naiyer, Sautès-Fridman, Catherine, Schreiber, Hans, Seliger, Barbara, Shiku, Hiroshi, Silva-Santos, Bruno, Smyth, Mark J., Speiser, Daniel E., Spisek, Radek, Srivastava, Pramod K., Talmadge, James E., Tartour, Eric, Van Der Burg, Sjoerd H., Van Den Eynde, Benoît J., Vile, Richard, Wagner, Hermann, Weber, Jeffrey S, Whiteside, Theresa L., Wolchok, Jedd D., Zitvogel, Laurence, Zou, Weiping, Kroemer, Guido
Published in Oncotarget (30.12.2014)
Published in Oncotarget (30.12.2014)
Get full text
Journal Article
Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression: Analysis of 2 Phase 3 Clinical Trials
Long, Georgina V, Weber, Jeffrey S, Larkin, James, Atkinson, Victoria, Grob, Jean-Jacques, Schadendorf, Dirk, Dummer, Reinhard, Robert, Caroline, Márquez-Rodas, Ivan, McNeil, Catriona, Schmidt, Henrik, Briscoe, Karen, Baurain, Jean-François, Hodi, F Stephen, Wolchok, Jedd D
Published in JAMA oncology (01.11.2017)
Published in JAMA oncology (01.11.2017)
Get more information
Journal Article
Evaluating the potential of relapse-free survival as a surrogate for overall survival in the adjuvant therapy of melanoma with checkpoint inhibitors
Coart, Elisabeth, Suciu, Stefan, Squifflet, Pierre, Saad, Everardo D., Moshyk, Andriy, de Schaetzen, Gaetan, Buyse, Marc, Weber, Jeffrey S., Eggermont, Alexander, Kotapati, Srividya
Published in European journal of cancer (1990) (01.09.2020)
Published in European journal of cancer (1990) (01.09.2020)
Get full text
Journal Article
Extended Dose Ipilimumab with a Peptide Vaccine: Immune Correlates Associated with Clinical Benefit in Patients with Resected High-Risk Stage IIIc/IV Melanoma
SARNAIK, Amod A, BIN YU, YELLIN, Michael, WEBER, Jeffrey S, DAOHAI YU, DAWN MORELLI, HALL, Maclean, BOGLE, Dilip, LULU YAN, TARGAN, Stephan, SOLOMON, Jolie, NICHOL, Geoff
Published in Clinical cancer research (15.02.2011)
Published in Clinical cancer research (15.02.2011)
Get full text
Journal Article
A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma
Hersh, Evan M., O’Day, Steven J., Powderly, John, Khan, Khuda D., Pavlick, Anna C., Cranmer, Lee D., Samlowski, Wolfram E., Nichol, Geoffrey M., Yellin, Michael J., Weber, Jeffrey S.
Published in Investigational new drugs (01.06.2011)
Published in Investigational new drugs (01.06.2011)
Get full text
Journal Article
BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells
Atay, Cigdem, Kwak, Taekyoung, Lavilla-Alonso, Sergio, Donthireddy, Laxminarasimha, Richards, Allison, Moberg, Valerie, Pilon-Thomas, Shari, Schell, Michael, Messina, Jane L, Rebecca, Vito W, Xiao, Min, Tan, Jiufeng, Zhang, Gao, Weber, Jeffrey S, Herlyn, Meenhard, Sarnaik, Amod A, Gabrilovich, Dmitry I
Published in Clinical cancer research (01.05.2019)
Published in Clinical cancer research (01.05.2019)
Get full text
Journal Article
American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment
Weber, Jeffrey S, Levit, Laura A, Adamson, Peter C, Bruinooge, Suanna, Burris, 4th, Howard A, Carducci, Michael A, Dicker, Adam P, Gönen, Mithat, Keefe, Stephen M, Postow, Michael A, Thompson, Michael A, Waterhouse, David M, Weiner, Susan L, Schuchter, Lynn M
Published in Journal of clinical oncology (20.01.2015)
Published in Journal of clinical oncology (20.01.2015)
Get full text
Journal Article
Cytotoxic T lymphocyte responses against melanocytes and melanoma
Chang, Gwendolen Y, Kohrt, Holbrook E, Stuge, Tor B, Schwartz, Erich J, Weber, Jeffrey S, Lee, Peter P
Published in Journal of translational medicine (27.07.2011)
Published in Journal of translational medicine (27.07.2011)
Get full text
Journal Article
Long-term outcomes in patients with advanced melanoma who had initial stable disease with pembrolizumab in KEYNOTE-001 and KEYNOTE-006
Hamid, Omid, Robert, Caroline, Daud, Adil, Carlino, Matteo S., Mitchell, Tara C., Hersey, Peter, Schachter, Jacob, Long, Georgina V., Hodi, F. Stephen, Wolchok, Jedd D., Arance, Ana, Grob, Jean Jacques, Joshua, Anthony M., Weber, Jeffrey S., Mortier, Laurent, Jensen, Erin, Diede, Scott J., Moreno, Blanca Homet, Ribas, Antoni
Published in European journal of cancer (1990) (01.11.2021)
Published in European journal of cancer (1990) (01.11.2021)
Get full text
Journal Article
Clinical and immune correlate results from a phase 1b study of the histone deacetylase inhibitor mocetinostat with ipilimumab and nivolumab in unresectable stage III/IV melanoma
Weber, Jeffrey S, Levinson, Benjamin A, Laino, Andressa S, Pavlick, Anna C, Woods, David M
Published in Melanoma research (01.10.2022)
Published in Melanoma research (01.10.2022)
Get more information
Journal Article
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
Hall, MacLean S, Mullinax, John E, Cox, Cheryl A, Hall, Amy M, Beatty, Matthew S, Blauvelt, Jamie, Innamarato, Patrick, Nagle, Luz, Branthoover, Holly, Wiener, Doris, Schachner, Benjamin, Martinez, Alberto J, Richards, Allison D, Rich, Carolyn J, Colón Colón, Marjorie, Schell, Michael J, Teer, Jamie K, Khushalani, Nikhil I, Weber, Jeffrey S, Mulé, James J, Sondak, Vernon K, Pilon-Thomas, Shari, Sarnaik, Amod A
Published in Clinical cancer research (15.12.2022)
Published in Clinical cancer research (15.12.2022)
Get full text
Journal Article
Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival
Weber, Jeffrey S., Poretta, Tayla, Stwalley, Brian D., Sakkal, Leon A., Du, Ella X., Wang, Travis, Chen, Yan, Wang, Yan, Betts, Keith A., Shoushtari, Alexander N.
Published in Cancer Immunology, Immunotherapy (01.04.2023)
Published in Cancer Immunology, Immunotherapy (01.04.2023)
Get full text
Journal Article